Bioiberica Overview
- Year Founded
-
1975

- Status
-
Acquired/Merged
- Employees
-
450

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Bioiberica General Information
Description
Operator of a global life science company committed to improving people, animal and plant health and well-being. The company specializes in identifying, extracting and developing APIs and ingredients and turns them into Heparin products to progress the pharmaceutical, nutraceutical, veterinary, feed and agricultural industries, enabling its customers to avail the solution for improving their lives.
Contact Information
Website
www.bioiberica.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
- C. Antic Camí de Tordera, 109-119
- Palafolls
- 08389 Barcelona
- Spain
+34 937 00 00 00
Bioiberica Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Bioiberica Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a global life science company committed to improving people, animal and plant health and well-being. The com
Pharmaceuticals
Barcelona, Spain
450
As of 2022
0000
0000-00-00
000000&0
Bioiberica Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Novartis India | Corporation | Mumbai, India | 00 | 00.000 | 00000000000 | 00.000 |
0000000000 0000000 | Corporation | Ingelheim Am Rhein, Germany | 00000 | |||
000000000000000 00 | Corporation | Lagos, Nigeria | 00 | 00000000 | ||
000000 00000 | Corporation | Mumbai, India | 0000 | 00000000 | ||
00000 | Corporation | Mumbai, India | 00000 | 0&0 |
Bioiberica Patents
Bioiberica Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4124335-A1 | Dermatological collar for non-human animals | Pending | 30-Jul-2021 | 0000000000 | 0 |
US-20230044738-A1 | Dermatological collar for non-human animals | Pending | 30-Jul-2021 | 0000000000 | |
US-20200102339-A1 | Sulphated disaccharides for the treatment of neuropathic pain | Active | 29-Mar-2017 | 00000000000 | |
ES-2684097-A1 | Sulfated disaccharides for the treatment of neuropathic pain (machine-translation by google translate, not legally binding) | Active | 29-Mar-2017 | 000000000 | 0 |
ES-2684097-B1 | Sulfated disaccharides for the treatment of neuropathic pain | Active | 29-Mar-2017 | C07H11/00 |
Bioiberica Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Luis Solera | Chief Executive Officer | ||
Jordi Vidal | Chief Financial Officer |
Bioiberica Signals
Bioiberica Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|